ELAHERE is a prescription medicine used to treat adults with folate
receptor–alpha positive ovarian cancer, fallopian tube
cancer, or primary peritoneal cancer who:
have not responded to or are no longer responding to treatment with
platinum-based chemotherapy and
have received 1 to 3 prior types of chemotherapy
Your healthcare provider will perform a test to make sure that ELAHERE is
right for you.
ELAHERE was FDA-approved based on a clinical study that measured how many
patients had a tumor response and how long that response lasted. Continued
approval is dependent on the results of an ongoing study to confirm the
benefit of ELAHERE.
ELAHERE is a prescription medicine used to treat adults with folate
receptor–alpha positive ovarian cancer, fallopian tube
cancer, or primary peritoneal cancer who:
have not responded to or are no longer responding to treatment with
platinum-based chemotherapy and
have received 1 to 3 prior types of chemotherapy
Your healthcare provider will perform a test to make sure that ELAHERE is
right for you.
ELAHERE was FDA-approved based on a clinical study that measured how many
patients had a tumor response and how long that response lasted. Continued
approval is dependent on the results of an ongoing study to confirm the
benefit of ELAHERE.
September is National Ovarian Cancer Awareness Month
This month and beyond, ImmunoGen recognizes all people living with and impacted by ovarian cancer. We remain committed to helping raise awareness and contributing to ongoing research in this disease space.
